While some say bringing expertise to a country where cancer cases are rising every year will bring hope, others say it may ...

Yelena Y. Janjigian, MD, discusses the standard approval of pembrolizumab plus trastuzumab and chemotherapy for the treatment ...

Professionals share coping strategies for navigating a breast cancer diagnosis, including how to manage difficult emotions, ...

Renier Brentjens, a CAR T-cell pioneer, views armored CAR T-cells as a promising avenue for treating solid tumors and ...

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science of addressing critical issues with CAR T cell therapy in patients with ...

In high doses, ivermectin can be toxic and cause central nervous system problems like blurred vision, confusion and seizures, ...

IgniteData has announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK) and AstraZeneca to launch its innovative Archer tool for Electronic Health Record (EHR)-to-Electronic Data ...

In just over a year since its US Food and Drug Administration (FDA) approval, pirtobrutinib (Jayprica) has become a standard ...

Pelabresib, a bromodomain and extraterminal domain inhibitor, plus ruxolitinib (a Janus kinase [JAK] inhibitor) improves ...

This is the 11th year that Little Eric’s Foundation participated, as an organization, in Cycle for Survival in New York City.

An international research team, led by scientists from Tel Aviv University and Sheba Medical Center, has unveiled an ...

The New York Genome Center announces Bing Ren, PhD, as the New Scientific Director and CEO of the New York Genome Center and Professor in the Departments of Genetics and Development, Biochemistry and ...